01 3Allergan Inc.
02 42Gowling Strathy & Henderson
03 1Norton Rose Fulbright Canada
04 2Smart & Biggar / Fetherstonhaugh
05 1Sun Pharma Canada Inc.
01 101332150
02 11335566
03 91338775
04 92072509
05 62108018
06 42132933
07 12190485
08 42302963
09 12309033
10 12578176
11 12586074
12 12659322
13 12914472
01 4CYCLOSPORINE
02 45Cyclosporine
01 33Capsule
02 3EMULSION
03 2Injectable Ampuls
04 3Ophthalmic Emulsion
05 7Oral Solution
06 1SOLUTION
01 102011-09-27
02 62012-04-16
03 12012-05-15
04 92012-06-26
05 92013-12-10
06 82014-09-26
07 22015-05-17
08 22025-10-10
09 12027-07-27
10 12033-08-23
Patent Expiration Date : 2015-05-17
Date Granted : 2003-08-26
Brand Name : RESTASIS
Patent Number : 2309033
Filing Date : 1995-05-17
Strength per Unit : 0.05%
Dosage Form : Ophthalmic Emulsion
Human Or VET : Human
Route of Administration : Topical Opthalmic
Patent Expiration Date : 2015-05-17
Date Granted : 2003-08-26
Patent Expiration Date : 2015-05-17
Date Granted : 2003-04-15
Brand Name : RESTASIS
Patent Number : 2190485
Filing Date : 1995-05-17
Strength per Unit : 0.05%
Dosage Form : Ophthalmic Emulsion
Human Or VET : Human
Route of Administration : Topical Opthalmic
Patent Expiration Date : 2015-05-17
Date Granted : 2003-04-15
Patent Expiration Date : 2012-05-15
Date Granted : 1995-05-16
Brand Name : RESTASIS
Patent Number : 1335566
Filing Date : 1989-04-19
Strength per Unit : 0.05%
Dosage Form : Ophthalmic Emulsion
Human Or VET : Human
Route of Administration : Topical Opthalmic
Patent Expiration Date : 2012-05-15
Date Granted : 1995-05-16
Patent Expiration Date : 2012-04-16
Date Granted : 2003-04-15
Brand Name : SANDIMMUNE
Patent Number : 2108018
Filing Date : 1992-04-16
Strength per Unit : unit = 1 ml 50 mg
Dosage Form : Injectable Ampuls
Human Or VET : Human
Route of Administration : injectable
Patent Expiration Date : 2012-04-16
Date Granted : 2003-04-15
Patent Expiration Date : 2012-04-16
Date Granted : 2003-04-15
Brand Name : NEORAL
Patent Number : 2108018
Filing Date : 1992-04-16
Strength per Unit : 50 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2012-04-16
Date Granted : 2003-04-15
Patent Expiration Date : 2014-09-26
Date Granted : 2001-10-23
Brand Name : NEORAL
Patent Number : 2302963
Filing Date : 1994-09-26
Strength per Unit : 50 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2014-09-26
Date Granted : 2001-10-23
Patent Expiration Date : 2012-04-16
Date Granted : 2003-04-15
Brand Name : NEORAL
Patent Number : 2108018
Filing Date : 1992-04-16
Strength per Unit : 100 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2012-04-16
Date Granted : 2003-04-15
Patent Expiration Date : 2014-09-26
Date Granted : 2001-10-23
Brand Name : NEORAL
Patent Number : 2302963
Filing Date : 1994-09-26
Strength per Unit : 100 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2014-09-26
Date Granted : 2001-10-23
Patent Expiration Date : 2012-04-16
Date Granted : 2003-04-15
Brand Name : NEORAL
Patent Number : 2108018
Filing Date : 1992-04-16
Strength per Unit : 25 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2012-04-16
Date Granted : 2003-04-15
Patent Expiration Date : 2014-09-26
Date Granted : 2001-10-23
Brand Name : NEORAL
Patent Number : 2302963
Filing Date : 1994-09-26
Strength per Unit : 25 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2014-09-26
Date Granted : 2001-10-23
